Abstract. Serum levels of diiodotyrosine (DIT) and urinary excretion rates of DIT and iodine were measured in 10 normal subjects after oral administration of 1.57 \g=m\molof DIT corresponding to 400 \ g=m\ gof iodine. Serum DIT concentrations rose promptly from a mean endogenous basal level of 0.23 nmol/l to maximum values between 6.0 and 20 nmol/l within 30 min to 1 h after DIT ingestion. Decreasing DIT levels were found in all subjects 2 h after DIT intake. Urinary excretion of intact DIT was low, being less than 1% of the administered dose of exogenous DIT within 2 days. In contrast, 52% of the iodine administered in the form of DIT was excreted in the urine in the same time interval.
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The rapid absorption of DIT from the gastrointestinal tract combined with rapid and almost complete metabolic degradation by deiodination make orally applied DIT seem a suitable iodine carrier compound for therapeutic purposes.
Ina recent comparative study on the effectiveness of iodine and thyroxine in the therapy of endemic goitre, the required iodine dose was administered in the form of 3,5-diiodo-L-tyrosine (DIT) instead of the usually applied potassium or sodium iodide (Hintze et al. 1985) . DIT was chosen by these authors because some pharmaceutical quality as¬ pects make it seem superior to iodide tablets, which require the presence of reducing agents to prevent oxidation of iodide to elementary iodine and to guarantee long-term pharmaceutical stabil¬ ity. Although DIT is known to be rapidly deiodinated in vivo and in vitro (Oswald 1910 (Glöbel 1977) . Crea¬ tinine in urine was determined by standard methods. 
Results
The time course of serum DIT levels in each individual after oral DIT administration is shown in Fig. 1 . DIT rose promptly from endogenous basal values between 0.09 and 0.53 nmol/1 to peak levels of 6.0-20 nmol/1 within 30 min to 1 h after DIT ingestion. Decreasing DIT levels were al¬ ready observed in all subjects 2 h after DIT intake. The rate of DIT elimination from blood slowed down after 5 to 8 h, leading to serum concentrations which were still above baseline levels 24 h after administration. Comparison of mean DIT concentrations in the total serum volume of 10 normal subjects after oral administration of 1.57 µ of DIT (lower curve) with results of a separate study, in which 10 other normal subjects had received a lower dose of 0.46 µ DIT iv (Meinhold et al. 1987) . The values obtained after iv DIT injection in the cited study were extrapolated to a dose of 1.57 µ of DIT (upper curve). 
